Trending News

#Biomarkers #Cancer research #National Institute for Health and Care Excellence (NICE) #Oncology #Prostate cancer #The Institute of Cancer Research

NICE rejects prostate cancer drug due to cost of genetic testing

The National Institute of Health and Care Excellence (NICE) has confirmed its decision not to recommend olaparib for previously treated metastatic prostate cancer in patients with BRCA gene mutations. The Institute of Cancer Research (ICR) has called the decision ‘disappointing’ and ‘frustrating’. It means that men in England and Wales… Read More

#Cancer Research #News #Trending News

Patient on ventilator
#Covid-19 #Diabetes #Long Covid

Diabetes drug could prevent severe Covid

A recent study by the University of Colorado School of Medicine shows that diabetes drug metformin is effective for preventing severe illness from Covid-19. The CU School of Medicine was part of a multi-site clinical trial into the effectiveness of metformin, ivermectin and fluvoxamine in non-hospitalised adults with Covid-19. … Read More

#Covid-19 #Editor's Choice #News #Trending News

#Antivirals #Monkeypox #Research study

Can a smallpox antiviral be used to treat monkeypox?

A new study has found that the antiviral tecovirimat (TPOXX) appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions. This University of California Davis Health (UC Davis Health) study is one of the earliest studies to assess and report the outcomes of treating patients… Read More

#News #Trending News

#Autoimmune disease #Diabetes #Drug discovery

Australian discovery boosts hopes of preventing Type 1 diabetes

Australian researchers based may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could prevent the autoimmune disease from taking hold. Mater Research and University of Queensland researchers have developed a biological agent, sRAGE, that boosts white blood cell function which is damaged in… Read More

#Editor's Choice #News #Trending News

#Covid-19 #Immunology #Immunology / Virology & Vaccines

Promising developments in pursuit to design pan-coronavirus vaccine

Researchers at the Francis Crick Institute in the UK, have shown that a specific area of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could offer some protection against new virus variants, common colds, and help prepare for future pandemics. Developing a vaccine that provides… Read More

#Editor's Choice #News #Trending News

#DNA #Institute of Cancer Research #Oncology

Junk DNA could lead to cancer, study says  

Non-coding or ‘junk’ DNA could contribute to the development of certain cancers due to how it disrupts the replication of the genome, scientists have discovered.   A team from The Institute of Cancer Research (ICR), London reconstituted the entire process of DNA replication in a test tube in… Read More

#News #Trending News

#Antibiotics #Antimicrobial resistance (AMR) #Vaccines #WHO

Urgency a must for global fight against AMR, report says  

Urgent access to vaccines that can fight and prevent infections, and curb the risk of antimicrobial resistance (AMR) is needed to save lives, according to a report by the World Health Organisation (WHO).  WHO has released the first-ever report1 looking at the pipeline of vaccines currently in… Read More

#News #Trending News

Back pain
#AstraZeneca #DNA #Oncology

Could this drug help repair nerve damage?  

Research from the University of Birmingham in the UK has indicated that a cancer therapy could help damaged nerves repair themselves following spinal injury.   The research shows that AstraZeneca’s candidate drug AZD1390 can block the response to DNA damage in nerve cells and promote regeneration of damaged… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Drug discovery #Immunotherapy #Synthetic biology

The summer issue of Drug Discovery World magazine is out now 

Featuring Specialty Spotlight: Immunotherapy, the magazine is available to download and read for free on the DDW App. Key features of the summer issue include: Why immunocompromised people are ‘forgotten’: Championing female leaders across drug discovery and development: Improving quality control for CAR T cell therapies, plus exclusive interviews and articles on… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Drug development #Events #Medtech #Public health

Back in-person for 2022: LSX World Congress returns

For the last seven years, the LSX World Congress has bought together biotech, medtech and healthtech executives to connect with the capital, intelligence, innovation, and partners they need to grow their businesses. Back in-person for 2022, the 8th Congress takes place 10-11 May at 133 Houndsditch in London. … Read More

#News #Trending News

First volunteers dosed with psychedelics in clinical trial 

Beckley Psytech, a company addressing neurological and psychiatric disorders through the application of psychedelic medicines, announced that the first healthy volunteers have been dosed in a Phase I clinical trial exploring the safety and pharmacokinetics of BPL-003, Beckley Psytech’s second formulation of 5-Methoxy-N, N-Dimethyltryptamine (5-MeO-DMT).  The study… Read More

#News #Trending News

#Analysis #Clinical trials #Data #Research #Ukraine

How war in Ukraine impacts global clinical development 

New global data analysis from Phesi shows the extent of the impact from the war in Ukraine on clinical development.   Phesi analysed pivotal trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities.   The findings  The findings show that… Read More

#News #Trending News

Woman reaches for inhaler
#Asthma #Data #Research

40% of asthma patients overusing inhalers, says data 

New results from an observational data analysis of asthma inhaler therapy found that short-acting beta2-agonist (SABA) reliever overuse is a global issue adversely impacting asthma outcomes.1,2   Data from across the SABA Use IN Asthma (SABINA) global programme have been published in The Journal of Allergy… Read More

#News #Trending News

#Clinical trials #Infectious diseases #Malaria

Landmark approval of child-friendly malaria treatment 

According to the Medicines for Malaria Venture (MMV),the Australian Therapeutic Goods Administration (TGA) has approved the use of single-dose Kozenis (tafenoquine) in children aged two years and above in combination with chloroquine for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria.  The approval… Read More

#News #Trending News